Highlights

Highlighted Articles
Published: (2024)

Highlighted Articles
Published: (2024)

Highlighted Articles
Published: (2024)

Highlighted Articles
Published: (2025)

Highlighted Articles
Published: (2025)

Highlighted Articles
Published: (2025)

Infection Risk Associated with High‐Efficacy Disease‐Modifying Agents in Multiple Sclerosis: A Retrospective Cohort Study
by: Jieni Li, et al.
Published: (2024)

Genetic Prediction of Smoking Cessation Medication Side Effects: A Genome‐Wide Investigation of Abnormal Dreams on Varenicline
by: Meghan J. Chenoweth, et al.
Published: (2024)

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T‐Cell Engagers Development in Oncology
by: Mohamed Elmeliegy, et al.
Published: (2024)

Optimizing Clinical Translation of Bispecific T‐cell Engagers through Context Unification with a Quantitative Systems Pharmacology Model
by: Xiaozhi Liao, et al.
Published: (2024)

Tracing Digital Therapeutics Research Across Medical Specialties: Evidence from ClinicalTrials.gov
by: Lars Masanneck, et al.
Published: (2024)

Pharmacotherapy to Improve Cognitive Functioning After Acquired Brain Injury: A Meta‐Analysis and Meta‐Regression
by: Ruud van der Veen, et al.
Published: (2024)

Correction to “Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals”
Published: (2024)

Identifying Drug–Drug Interactions in Spontaneous Reports Utilizing Signal Detection and Biological Plausibility Aspects
by: Elpida Kontsioti, et al.
Published: (2024)

Pathway‐Based Similarity Measurement to Quantify Transcriptomics Similarity Between Human Tissues and Preclinical Models
by: Paarth Parekh, et al.
Published: (2024)

Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms
by: Caroline Marra, et al.
Published: (2024)

Pharmacokinetic, Safety, and Pharmacodynamic Profiles of Saroglitazar Magnesium in Cholestatic Cirrhosis With Hepatic Impairment and Participants With Renal Impairment
by: Raj Vuppalanchi, et al.
Published: (2024)

Mapping the Clinical Development Trajectory of Cell and Gene Therapy Products
by: Magdi Elsallab, et al.
Published: (2024)

Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease
by: Pamela Navarro‐Gonzales, et al.
Published: (2024)

Corrections to “Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions”
Published: (2024)

Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine
by: Qi Liu, et al.
Published: (2024)

In this Issue
Published: (2024)

New Horizons of Model Informed Drug Development in Rare Diseases Drug Development
by: Amitava Mitra, et al.
Published: (2024)

Rare Diseases Linked to Mutations in Vitamin Transporters Expressed in the Human Blood–Brain Barrier
by: Sook Wah Yee, et al.
Published: (2024)

Model‐Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen
by: Peter N. Morcos, et al.
Published: (2024)

Transcriptomic Profiles Associated with Experimental Placebo Effects in Chronic Pain
by: Luana Colloca, et al.
Published: (2024)

Application and Quality of Model‐Based Meta‐Analysis in Pharmaceutical Research: A Systematic Cross‐Sectional Analysis and Practical Considerations
by: Zhirong Yang, et al.
Published: (2024)

ASCPT News
Published: (2024)

In This Issue
Published: (2024)

Impact of CYP2C19 Phenotype on Escitalopram Response in Geriatrics: Based on Physiologically‐Based Pharmacokinetic Modeling and Clinical Observation
by: Yoo Jin Jang, et al.
Published: (2024)

Trust in the Food and Drug Administration: A National Survey Study
by: William B. Feldman, et al.
Published: (2024)

The Future of Machine Learning Within Target Identification: Causality, Reversibility, and Druggability
by: Jake P. Taylor‐King, et al.
Published: (2024)

The Use of Real‐World Evidence for Regulatory Decisions in China
by: Jiayue Xu, et al.
Published: (2024)

PharmVar GeneFocus: CYP4F2
by: Pablo Zubiaur, et al.
Published: (2024)

Questioning Conclusions and Statements on the German HTA System: A Critical Perspective
by: Jörg Tomeczkowski, et al.
Published: (2024)

Capturing Synergy Holistically in Psychedelic Clinical Trials: Assessing Processes in Addition to Outcomes
by: Terence H.W. Ching, et al.
Published: (2024)